Kestra Private Wealth Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,318
Closed -$658K 1637
2025
Q1
$658K Buy
10,318
+1,004
+11% +$58.3K 0.01% 845
2024
Q4
$445K Sell
9,314
-9,161
-50% -$470K 0.01% 972
2024
Q3
$1.06M Buy
18,475
+7,310
+65% +$419K 0.02% 600
2024
Q2
$585K Buy
11,165
+248
+2% +$10.9K 0.01% 767
2024
Q1
$444K Sell
10,917
-282
-3% -$10.6K 0.01% 849
2023
Q4
$414K Buy
+11,199
New +$422K 0.01% 807

Other funds holding HALO

Kestra Private Wealth Services's HALO Position: Q2 2025 in Review

Kestra Private Wealth Services sold out of Halozyme (HALO) in Q2 2025, closing a stake of 10,318 shares — an estimated $658K sold.

Kestra Private Wealth Services first reported a position in HALO in Q4 2023 and held it in 6 quarters. The position peaked at $1.06M in Q3 2024. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Kestra Private Wealth Services reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Kestra Private Wealth Services sold 10,318 Halozyme shares in Q2 2025, an estimated $658K.
  • Kestra Private Wealth Services first reported a position in Halozyme in Q4 2023 and held it in 6 quarters.
  • Kestra Private Wealth Services's Halozyme position peaked at $1.06M in Q3 2024.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Kestra Private Wealth Services's 13F filing for Q2 2025, filed 7 Aug 2025.